List of Toviaz drug patents

Toviaz is owned by Pfizer.

Toviaz contains Fesoterodine Fumarate.

Toviaz has a total of 8 drug patents out of which 2 drug patents have expired.

Expired drug patents of Toviaz are:

  • US6858650*PED
  • US6858650

Toviaz was authorised for market use on 31 October, 2008.

Toviaz is available in tablet, extended release;oral dosage forms.

Toviaz can be used as treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.

The generics of Toviaz are possible to be released after 07 December, 2027.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US6858650 PFIZER Stable salts of novel derivatives of 3,3-diphenylpropylamines
Jul, 2022

(6 months ago)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6858650

(Pediatric)

PFIZER Stable salts of novel derivatives of 3,3-diphenylpropylamines
Jan, 2023

(25 days ago)

US8501723 PFIZER Pharmaceutical compositions comprising fesoterodine
Jun, 2027

(4 years from now)

US8088398 PFIZER Pharmaceutical compositions comprising fesoterodine
Jun, 2027

(4 years from now)

US7807715 PFIZER Pharmaceutical compositions comprising fesoterodine
Jun, 2027

(4 years from now)

US7807715

(Pediatric)

PFIZER Pharmaceutical compositions comprising fesoterodine
Dec, 2027

(4 years from now)

US8088398

(Pediatric)

PFIZER Pharmaceutical compositions comprising fesoterodine
Dec, 2027

(4 years from now)

US8501723

(Pediatric)

PFIZER Pharmaceutical compositions comprising fesoterodine
Dec, 2027

(4 years from now)

Exclusivity Exclusivity Expiration
New Indication (I) Jun 17, 2024
Pediatric Exclusivity (PED) Dec 17, 2024

Drugs and Companies using FESOTERODINE FUMARATE ingredient

Market Authorisation Date: 31 October, 2008

Treatment: Treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency

Dosage: TABLET, EXTENDED RELEASE;ORAL

How can I launch a generic of TOVIAZ before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in